UCSF

Tagged: pharmacodynamics

Aweeka study details impact of HIV drugs on malaria treatment in children

Sub-Saharan Africa is home to a billion people and to overlapping health burdens, including the world’s highest rates of both malaria and HIV infection.

Research: pediatric meningitis dosing; cancer drug resistance; gene-testing economics

Computer models provide optimal dosing for pediatric TB meningitis

Giacomini to lead largest study of genetic, ethnic differences in effectiveness of leading diabetes drug

In people with type 2 diabetes, the body is less able to use the hormone insulin to regulate blood sugar. The disease affects 350 million patients globally—including 29 million in the United States, where it is the leading cause of blindness, kidney failure, and non-accident-related amputations.

Yang study demonstrates simulator to study antibiotic dosing against biofilms

Nearly every human bacterial infection—including some of the most serious, life threatening, and costly to treat—can take the form of a biofilm, in which bacteria aggregate into structured communities that enclose themselves within a secreted slime.

Aweeka co-leads new study of drugs to prevent malaria in young children, pregnant women

Francesca Aweeka, PharmD, a faculty member in the School’s Department of Clinical Pharmacy, will co-lead a new five-year, $3.4 million study funded by the National Institutes of Health (NIH) to address one of the world’s most vexing health problems—preventing malaria, especially in the most vulnerable populations, pregnant women and young children in Africa.

Katherine Yang, PharmD, MPH

Professor

My research focuses on pharmacodynamic optimization for the treatment of multi-drug resistant organisms such as Pseudomonas aeruginosa. I am particularly interested in dosing strategies to combat biofilm-mediated infections such as cystic fibrosis.

Benet Receives Magic Bullet Lifetime Achievement Award

Leslie Z. Benet, PhD, UCSF School of Pharmacy faculty member, received the 2008 Paul Ehrlich Magic Bullet Lifetime Achievement Award at the Second World Conference on Magic Bullets, which convened in Nuremberg, Germany, in early October.

Giacomini and Benet Honored by International Peers

Kathy M. Giacomini, PhD, chair, department of biopharmaceutical sciences and Leslie Z. Benet, PhD, professor in the same department, were both honored at the Pharmaceutical Sciences World Congress, held May 29 to June 4, 2004 in Kyoto, Japan.

Leslie Z. Benet Named Thomson ISI Highly Cited Researcher

Leslie Z. Benet, PhD, was named a Thomson ISI Highly Cited Researcher in December 2003. The designation means that Benet's research publications on pharmacokinetics and pharmacodynamics have been extensively cited by other scientists in their publications. Citation is an important way to measure influence in science through time.